Johnson is responsible for all pharmaceutical development and pre-clinical research for the company including device development for the aerosol program manufacturing process development as well as research activities related to Surfaxin and the product pipeline. Dr. Johnson brings over 16 years of research and development experience in medical devices process development drug delivery and complex formulations of both small and large molecules. Prior to Discovery Dr. Johnson held leadership positions at Corixa on a number of Clinical and Preclinical programs utilizing proteins peptides advanced delivery systems and gene therapy. Dr. Johnson previously consulted at Sontra Medical and provided technical expertise to Eastman Kodak as well as authored an extensive list of patents and publications. Dr. Johnson received his Ph.D. in Chemical Engineering and his M.S. in Chemical Engineering Practice from the Massachusetts Institute of Technology and his B.S. in Chemical Engineering from the University of California Davis.
|